Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD)

NCT02709746 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

784

Enrollment

INDUSTRY

Sponsor class

Conditions

Depressive Disorder, Major

Interventions

DRUG: Vortioxetine 10 mg/day
DRUG: Vortioxetine 20 mg/day
DRUG: Fluoxetine 20 mg/day
OTHER: Placebo

Sponsor

H. Lundbeck A/S

Collaborators

[object Object]